IPO > IPO details

< Back

Medicamen Organics Limited


Issue Price

₹32- ₹34

per equity share

Issue Size

22.24 lakhs

equity share

Face Value

₹ 10

per equity share

Market Lot


equity share

Please note

Listing at NSE

Medicamen Organics Limited

Important Dates

IPO Open Date

21 Jun 2024

IPO Close Date

25 Jun 2024

Allotment Date

26 Jun 2024

Initiation of Refunds

27 Jun 2024

Credit of Shares to Demat Account

27 Jun 2024

IPO Listing Date

28 Jun 2024

UPI Mandate Expiry Date

25 Jun 2024

IPO Details

Medicamen Organics has come up with an offering of a public issue. This upcoming IPO is offering a fresh issue of up to 3,100,000 equity shares; the total aggregated size of an offer is accumulated to 3,100,000 equity shares at a price of Rs 32 to Rs 34 per share worth Rs 10.53 Crore. This new IPO is being made through a book-built issue type with a reservation of not less than 50% of the net issue being offered to qualified institutional buyers, retail investors being offered not less than 35% of the net issue, and not less than 15% of the net issue is reserved for HNI category. This IPO will be open for subscription from June 21, 2024, till June 25, 2024, whereas the listing date is decided on June 28, 2024, and refund initiation for those who will not get allotted the share will be on June 27, 2024. However, keep in mind that the public offering is proposed to be listed on the BSE exchange on an SME segment.

Don't let another opportunity slip away. Check your IPO status now!

Check Allotment Status

About Medicamen Organics Limited

About Medicamen Organics Limited Medicamen Organics Limited was established in 1995. It manufactures and supplies pharmaceutical dosages such as tablets, capsules, oral liquids, creams, gels, syrups, suspensions and dry powders, which include generic forms. These products are supplied majorly to governments (both state and central) and private sector companies, sometimes as contract manufacturers or third-party manufacturers. The drugstore has an offering of 84 items, including antibacterial agents, antidiarrheal preparations, antifungals, antimalarials, antidiabetics, proton pump inhibitors, antihistamines, antihypertensives, lipid preparations, anti-protozoans, multivitamins with minerals; non-steroidal anti-inflammatory drugs (NSAIDs). Their distribution networks cover India and other overseas marketplaces like Africa, CIS nations and some South East Asian countries, for instance, Congo, Benin, Cameroon, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, Kenya, via the use of third-party distributors. Medicamen Organics operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering 21,536 square feet. As of September 30, 2023, the company has established contract manufacturing agreements with 38 domestic partners and 12 merchant exporters. The company employed a total of 116 people as of this date.

Parent Organisation




Managing Director

Bal Kishan Gupta

IPO Objectives

The company proposed to allocate the Net Proceeds from the issue towards several key objectives. Firstly, a portion of the funds will be dedicated to covering expenses associated with product registration in international markets. Next, the company intends to update its plant and enhance production capacity to meet growing demand. Furthermore, a significant part of the proceeds will be used to support the working capital requirements of the company and some allocation towards general corporate purposes

How to apply for IPO

  • Login to your Bigul account and select the issue in the current IPO section
  • Enter the number of lots and price at which you wish to apply for
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
  • You will receive a mandate notification to block funds in your UPI app
  • Approve the mandate request on your UPI and funds will be blocked

Let's Open Free Demat Account